International Consensus on Pemphigus Diagnosis and Treatment Published
An international panel has published recommendations for the diagnosis and management of pemphigus, a spectrum of rare autoimmune mucocutaneous bullous diseases. The recommendations appear in the March 2020 issue of the Journal of the American Academy of Dermatology.
Diagnosis of pemphigus can take months, the panel explained, and because of a lack of large-scale trials evaluating treatment efficacy, regimens vary greatly. In recent years, the first international guidelines for pemphigus management were published by the European Dermatology Forum and the European Academy of Dermatology and Venereology. They lacked involvement from countries outside of Europe, however, causing some experts to question their generalizability.
The International Bullous Diseases Consensus Group used the European Dermatology Forum and the European Academy of Dermatology and Venereology guidelines as a basis for a Delphi process. More than 90 international blistering disease experts were involved in the undertaking to arrive at the newest pemphigus recommendations.
“Each recommendation represents the majority opinion,” the panel wrote, “and therefore may not reflect all possible treatment options available.”
Diagnosis of pemphigus, according to the recommendations, requires clinical presentation and histopathology consistent with the disorder and either a positive direct immunofluorescence microscopy (DIF) of perilesional skin or serological detection of autoantibodies against epithelial cell surface antigens.
Management should be by dermatologists with experience in treating bullous disease. If pemphigus is extensive, hospitalization is typically required until bullous eruptions are controlled.
The recommendations list corticosteroids and anti-CD20 monoclonal antibodies as first-line treatments. Azathioprine and mycophenolate mofetil are recommended first-line corticosteroid-sparing agents.
The guidance also covers initial evaluation, other treatment supports, patient education, strategies for maintenance therapy, medication tapering at remission, and areas of focus for future research involving pemphigus. —Jolynn Tumolo
Reference
Murrell DF, Peña S, Joly P, et al. Diagnosis and management of pemphigus: recommendations of an international panel of experts. Journal of the American Academy of Dermatology. 2020;82(3):575-585.e1.


